2025. Pharmacological Evaluation of CB2 Receptor Modulator in the Treatment of Neuropathic Pain. Journal of Carcinogenesis. 24, 2s (Sep. 2025), 867–885. DOI:https://doi.org/10.64149/J.Carcinog.24.2s.867-885.